Skip To Main Content
Patrick Temple-West on Muck Rack

Patrick Temple-West

Verified
New York
As seen in: Financial Times, LinkedIn, MSN, MSN Canada, MSN UK, UOL, HuffPost, Reuters, Yahoo News, Los Angeles Times, NBC News and
Journalist @FT. Previously @Politico, @Reuters. Studied @MedillSchool, @saintjosephs. ودرس العربية @SAISHopkins.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Patrick

Contact Patrick, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Consultants head for an AI showdown — with their own clients

|
By Stephen Foley Verified, Patrick Temple-West Verified, Gregory Meyer Verified, Florian Muller Verified
| Financial Times Verified
Consultants are on a collision course with their clients over the cost of giant IT projects, as companies look to AI to cut spending on...
Open in Who Shared View Duplicates (4) Issue with article?

Pharma stocks soar as investors seek AI alternatives

|
By Aanu Adeoye Verified, Patrick Temple-West Verified, Clara Murray Verified
| Financial Times Verified
Pharmaceutical stocks have had a record year so far with drugmakers hitting fresh highs in August, as investors have sought to diversify...
Open in Who Shared Issue with article?

Moderna Shares Nearly Triple on Skin Cancer Vaccine Success

|
By Patrick Temple-West Verified, Stefania Palma Verified
| anr.news
Moderna Shares Nearly Triple on Skin Cancer Vaccine Success By Patrick Temple-West in New York and Stefania Palma in London Drugmaker’s melanoma shot developed with Merck delivers positive outcome in late-stage trial. Shares in US vaccine maker Moderna nearly tripled after the company reported successful trial results for an experimental skin cancer therapy.
Open in Who Shared View Duplicates (2) Issue with article?
See all 1,367 licensed articles (1,440 Total)